ANDREW TIMPSON
@Silverarc Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters
Portfolio positions
This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MRUSMerus N V
| 7.13% | $31.747M 635,439 shares@ $49.96 avg price | Increased 1.9% |
INSMInsmed Inc
| 5.71% | $25.382M 347,695 shares@ $73.0 avg price | Increased 148.36% |
AKROAkero Therapeutics Inc
| 4.13% | $18.357M 639,840 shares@ $28.7 avg price | Increased 2.37% |
VCYTVeracyte Inc
| 3.6% | $16.018M 470,565 shares@ $34.05 avg price | Increased 66.73% |
RYTMRhythm Pharmaceuticals Inc
| 3.01% | $13.39M 255,578 shares@ $52.39 avg price | Increased 38.41% |
COGTCogent Biosciences Inc
| 2.97% | $13.191M 1.221M shares@ $10.81 avg price | Increased 1.26% |
ORICOric Pharmaceuticals Inc
| 2.54% | $11.27M 1.099M shares@ $10.26 avg price | Increased 2.21% |
PSTXPoseida Therapeutics Inc
| 2.37% | $10.546M 3.688M shares@ $2.86 avg price | Increased 2.21% |
VRNAVerona Pharma Plc
| 2.26% | $10.037M 348,866 shares@ $28.78 avg price | Increased 14.53% |
GERNGeron Corp
| 1.84% | $8.179M 1.802M shares@ $4.55 avg price | Increased 80.29% |